Get started Log in

HLS — HLS Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
CA$133.23m
Enterprise Value
CA$178.10m
Revenue
$55.50m

Brief: HLS Therapeutics Announces Updates To Its Board Of Directors
22/06/2023 11:36
Brief: HLS Therapeutics Announces Agreement With Polar Asset Management Partners
08/06/2023 11:57
Brief: Hls Therapeutics Announces Q1 Fiscal 2023 Financial Results
11/05/2023 13:20
Brief: Hls Therapeutics Announces CEO Transition
17/04/2023 12:07
Canada Research Roundup: Alimentation Couche-Tard, Empire Company, Premium Brands Holdings
17/03/2023 07:19
Brief: Hls Therapeutics Announces Board Appointment
29/11/2022 11:43
Brief: Hls Therapeutics Announces Q3 Fiscal 2022 Financial Results
10/11/2022 12:46
Brief: Hls Therapeutics Announces Updates To Its Credit Agreement
03/10/2022 11:33
Brief: HLS Therapeutics reports Q2 results
11/08/2022 11:47
Brief: HLS Therapeutics - Effective August 1, Entered Product Listing Agreement With Saskatchewan Drug Plan, For Listing & Public Reimbursement Of Vascepa
02/08/2022 12:11
Brief: HLS Says Vascepa Is Now Reimbursed By Ontario's Provincial Drug Plan
25/07/2022 11:32
Brief: HLS Therapeutics Obtains Public Reimbursement For Vascepa In New Brunswick And With Other Public Payors
22/06/2022 11:39
Founder Bill Wells To Retire
24/05/2022 23:18
Brief: HLS Therapeutics Obtains Public Reimbursement For Vascepa In Quebec
24/05/2022 12:42
Brief: HLS Therapeutics Announces Q1 Fiscal 2022 Financial Results
05/05/2022 12:59
Brief: HLS Therapeutics Completes Negotiations With PCPS For Vascepa
26/04/2022 11:34
Brief: HLS Therapeutics Announces Q4, Fiscal 2021 Financial Results
17/03/2022 10:32
Brief: Hls Therapeutics Establishes Automatic Share Purchase Plan
20/12/2021 11:42
Brief: Saladax Biomedical And Hls Therapeutics Strengthen Partnership With An Exclusive Distribution Agreement For Canada
18/11/2021 18:29
Brief: HLS Therapeutics Announces Q3 Fiscal 2021 Financial Results
04/11/2021 12:53